Arrhythmias & electrophysiologyCohort study

Atrial Fibrillation Cycle Length Dynamics During Pulmonary Vein Isolation and Posterior Wall Pulsed Field Ablation

Heart RhythmPublished

  • multicenter observational study
  • consecutive patients

Authors' conclusion

Post-PVI fast LAPW activity does not predict recurrence after LAPWA in PersAF patients. CS-CL prolongation >23.5% after LAPWA may serve as a useful real-time marker of effective substrate modification and arrhythmia control.

Study context

Population
Consecutive persistent atrial fibrillation (PersAF) patients undergoing first-time pulmonary vein isolation (PVI) plus-LAPWA with a pentaspline pulsed field ablation (PFA) catheterpatients included
Participants
270 patients
Exposure
Post-PVI LAPW-CL and PFA-induced atrial fibrillation cycle length (AF-CL) (CS-CL) prolongation as predictors of arrhythmia recurrence after PVI plus left atrial posterior wall ablation (LAPWA)

Main finding

As reported in the abstract

12-month ATA-free survival · 12 months

Overall 12-month atrial tachyarrhythmia (ATA)-free survival

72.6%

Observational data: associations, not effects.

Further findings

Arrhythmia recurrence by fast LAPW activity

ComparisonHR (95% CI)P value
Fast LAPW activity · not associated with arrhythmia recurrence1.263 (0.739–2.160)P = 0.393

Arrhythmia recurrence by CS-CL prolongation

ComparisonHR (95% CI)P value
greater CS-CL prolongation · independently associated0.298 (0.017–0.520)P < 0.001
  • Arrhythmia recurrence by CS-CL prolongation: independently associated with lower arrhythmia recurrence risk

CS-CL increase >23.5% from baseline for predicting ATA-free survival

sensitivity
0.65
specificity
0.72

Original publication

Atrial Fibrillation Cycle Length Dynamics During Pulmonary Vein Isolation and Posterior Wall Pulsed Field Ablation. Heart Rhythm. Published 24 September 2026. doi:10.1016/j.hrthm.2026.09.036

Summarised from the published abstract; every number is checked against it